Karin Dilger

1.9k total citations
36 papers, 1.1k citations indexed

About

Karin Dilger is a scholar working on Epidemiology, Surgery and Pharmacology. According to data from OpenAlex, Karin Dilger has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Surgery and 8 papers in Pharmacology. Recurrent topics in Karin Dilger's work include Drug Transport and Resistance Mechanisms (8 papers), Inflammatory Bowel Disease (8 papers) and Microscopic Colitis (7 papers). Karin Dilger is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Inflammatory Bowel Disease (8 papers) and Microscopic Colitis (7 papers). Karin Dilger collaborates with scholars based in Germany, Ukraine and Russia. Karin Dilger's co-authors include Ulrich Klotz, Martin F. Fromm, Ulrich Beuers, Matthias Schwab, Ute Hofmann, Michel Eichelbaum, Heyo K. Kroemer, Gerd Mikus, Roland Greinwald and Christoph Reichel and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Karin Dilger

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Dilger Germany 21 371 288 272 263 227 36 1.1k
P Bories France 13 512 1.4× 244 0.8× 435 1.6× 310 1.2× 333 1.5× 36 1.2k
A. Lazar Germany 11 742 2.0× 172 0.6× 157 0.6× 371 1.4× 849 3.7× 33 1.6k
S Bondesen Denmark 25 529 1.4× 243 0.8× 257 0.9× 641 2.4× 705 3.1× 50 1.8k
Julie Borland United States 26 339 0.9× 154 0.5× 97 0.4× 249 0.9× 90 0.4× 52 2.0k
G Babany France 21 405 1.1× 220 0.8× 488 1.8× 154 0.6× 65 0.3× 56 1.3k
Marina Kacevska Australia 14 194 0.5× 384 1.3× 373 1.4× 74 0.3× 125 0.6× 14 1.2k
Richard H. Moseley United States 22 321 0.9× 531 1.8× 144 0.5× 424 1.6× 58 0.3× 81 1.5k
Averell H. Sherker United States 26 606 1.6× 204 0.7× 400 1.5× 480 1.8× 55 0.2× 47 1.6k
Darlene Barr United States 16 114 0.3× 547 1.9× 644 2.4× 346 1.3× 241 1.1× 33 1.6k
Donald L. Kaminski United States 25 285 0.8× 279 1.0× 138 0.5× 1.2k 4.4× 193 0.9× 87 2.1k

Countries citing papers authored by Karin Dilger

Since Specialization
Citations

This map shows the geographic impact of Karin Dilger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Dilger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Dilger more than expected).

Fields of papers citing papers by Karin Dilger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Dilger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Dilger. The network helps show where Karin Dilger may publish in the future.

Co-authorship network of co-authors of Karin Dilger

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Dilger. A scholar is included among the top collaborators of Karin Dilger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Dilger. Karin Dilger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schölmerich, Jürgen, Klaus Fellermann, Frank Seibold, et al.. (2016). A Randomised, Double-blind, Placebo-controlled Trial ofTrichuris suisova in Active Crohn’s disease. Journal of Crohn s and Colitis. 11(4). jjw184–jjw184. 54 indexed citations
2.
Kreisel, Wolfgang, Peter Deibert, Limas Kupčinskas, et al.. (2014). The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study. Digestive and Liver Disease. 47(2). 144–150. 39 indexed citations
3.
Dilger, Karin, Luis López Lázaro, Claudia Marx, Christian Bussmann, & Alex Straumann. (2013). Active Eosinophilic Esophagitis Is Associated with Impaired Elimination of Budesonide by Cytochrome P450 3A Enzymes. Digestion. 87(2). 110–117. 15 indexed citations
4.
Angelberger, Sieglinde, Elke Schaeffeler, Alexander Teml, et al.. (2013). Mucosal Improvement in Patients With Moderate to Severe Postoperative Endoscopic Recurrence of Crohn’s Disease and Azathioprine Metabolite Levels. Inflammatory Bowel Diseases. 19(3). 590–598. 14 indexed citations
5.
Groß, Volker, Ivan Bunganič, E. А. Belousova, et al.. (2010). 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial. Journal of Crohn s and Colitis. 5(2). 129–138. 51 indexed citations
6.
Andus, Tilo, Andrey Baranovsky, Ingolf Cascorbi, et al.. (2010). Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis. Inflammatory Bowel Diseases. 16(11). 1947–1956. 47 indexed citations
7.
Dilger, Karin, Jörg Halter, Hartmut Bertz, et al.. (2009). Pharmacokinetics and Pharmacodynamic Action of Budesonide after Buccal Administration in Healthy Subjects and Patients with Oral Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 15(3). 336–343. 21 indexed citations
8.
Dilger, Karin, Richard Fux, Daniel Röck, Klaus Mörike, & C. H. Gleiter. (2007). Effect of High‐Dose Metronidazole on Pharmacokinetics of Oral Budesonide and Vice Versa: A Double Drug Interaction Study. The Journal of Clinical Pharmacology. 47(12). 1532–1539. 12 indexed citations
9.
Dilger, Karin, et al.. (2005). No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis. Hepatology. 41(3). 595–602. 37 indexed citations
10.
Dilger, Karin, Matthias Schwab, & Martin F. Fromm. (2004). Identification of Budesonide and Prednisone as Substrates of the Intestinal Drug Efflux Pump P-glycoprotein. Inflammatory Bowel Diseases. 10(5). 578–583. 70 indexed citations
11.
Escher, Johanna C., Karin Dilger, Dietmar Trenk, et al.. (2004). Pharmacokinetics of Mesalazine Pellets in Children With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 10(5). 626–631. 14 indexed citations
12.
Grünhage, F, et al.. (2003). Pharmacokinetics and Pharmacodynamic Action of Budesonide in Early– and Late–Stage Primary Biliary Cirrhosis. Hepatology. 38(1). 196–202. 105 indexed citations
13.
Brenner, Stefanie S., Karin Dilger, Thomas E. Mürdter, et al.. (2003). Influence of Age and Cytochrome P450 2C9 Genotype on the Steady-State Disposition of Diclofenac and Celecoxib. Clinical Pharmacokinetics. 42(3). 283–292. 64 indexed citations
14.
Dilger, Karin, Peter Meisel, Ute Hofmann, & Michel Eichelbaum. (2000). Disposition of Propafenone in a Poor Metabolizer of CYP2D6 With Gilbert's Syndrome. Therapeutic Drug Monitoring. 22(3). 366–368. 2 indexed citations
15.
Hofmann, Ute, et al.. (2000). Determination of propafenone and its phase I and phase II metabolites in plasma and urine by high-performance liquid chromatography–electrospray ionization mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 748(1). 113–123. 26 indexed citations
16.
Dilger, Karin, Klaus Eckhardt, Ute Hofmann, et al.. (1999). Chronopharmacology of intravenous and oral modified release verapamil. British Journal of Clinical Pharmacology. 47(4). 413–419. 25 indexed citations
17.
Dilger, Karin, et al.. (1999). Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline. British Journal of Clinical Pharmacology. 48(3). 438–444. 37 indexed citations
18.
Fromm, Martin F., Karin Dilger, Dagmar Busse, et al.. (1998). Gut wall metabolism of verapamil in older people: effects of rifampicin‐mediated enzyme induction. British Journal of Clinical Pharmacology. 45(3). 247–255. 39 indexed citations
19.
Dilger, Karin, et al.. (1998). Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction*. Clinical Pharmacology & Therapeutics. 63(5). 552–560. 76 indexed citations
20.
Dilger, Karin, et al.. (1997). CYP2E1 activity in patients with alcoholic liver disease. Journal of Hepatology. 27(6). 1009–1014. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Bories Breakdown of academic impact, for papers by A. Lazar Breakdown of academic impact, for papers by S Bondesen Breakdown of academic impact, for papers by Julie Borland Breakdown of academic impact, for papers by G Babany Breakdown of academic impact, for papers by Marina Kacevska Breakdown of academic impact, for papers by Richard H. Moseley Breakdown of academic impact, for papers by Averell H. Sherker Breakdown of academic impact, for papers by Darlene Barr Breakdown of academic impact, for papers by Donald L. Kaminski
Rankless by CCL
2026